Wilmington Savings Fund Society’s Corcept Therapeutics CORT Stock Holding History

Wilmington Savings Fund Society’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$870	Buy	+10	New	+$604	﹤0.01%	1406

Other funds holding CORT

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

Wilmington Savings Fund Society's CORT Position: Q2 2026 in Review

Wilmington Savings Fund Society opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 10 shares worth $870. The stake represents ﹤0.01% of the portfolio and ranks #1406 among its holdings.

92 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

Wilmington Savings Fund Society held 10 shares of Corcept Therapeutics worth $870 as of Q2 2026.
Corcept Therapeutics was a new Wilmington Savings Fund Society position in Q2 2026.
Corcept Therapeutics made up ﹤0.01% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #1406 holding.
92 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.